While Chen Xia was still arranging to open a textile factory, several subsequent papers were published in "The Lancet".

Especially the latest research on asthma treatment.

Changing the use of hormones from oral and intravenous drops to a nebulization inhalation method with smaller side effects, lower hormone content and better efficacy, this innovative treatment plan immediately attracted the attention of doctors around the world.

It is a good thing for clinicians to pay attention.

What bad intentions can doctors have? Isn’t it just that they want to have more clinical medicines, better serve patients, and also show their medical standards.

Besides, the medicine is not used in vain. "Trial Fees" or "Teaching Fees" or so on. No matter which pharmaceutical company representative comes, you have to give it to it.

But the paper also attracted strong attention from several international pharmaceutical giants, and these capital tycoons are not that simple.

The spring river water warm duck prophet, Xiangjiang Pumpkin Vine Company selected a partner for several drugs used in the four-link therapy, and initially chose only three largest pharmaceutical companies on each continent.

This includes Huiduan Pharmaceuticals from the Mold Country, Glaxo History Department of Europe, and Takeda Pharmaceuticals from Japan. These three companies are basically in the leading position.

But this leader just says that the company is the largest and has the greatest influence. However, there are still many pharmaceutical companies in the world that have strong strength and own flagship products and monopoly drugs.

For example, "Lilai Pharmaceutical" in Mold Country

In Mold Country, this is a pharmaceutical giant second only to Pfizer and Johnson. Of course, their flagship products are mainly insulin and some biological agents.

These products have a high technological content. For example, biologics are not only used for tumor treatment, but also demonstrate obvious advantages that no traditional drug can have in the treatment of rheumatoid arthritis.

Because of its monopoly position, drug prices are set very high and profits are high, which also leads to Lilai Pharmaceutical being ambitious and always wants to defeat Pfizer Pharmaceutical as its boss.

After Pfizer Pharmaceuticals has made a lot of money in the market for digestive disease drugs in Mold Country after patents such as omeprazole and clarithromycin, it has made all companies jealous.

Later, the birth of "sildenafil".

Before everyone could react, they were immediately intercepted by GlaxoShiko. The two companies set up a wholly-owned company to produce it themselves. Everyone can only see this super big cake.

Now a series of atomized inhalation drugs and anti-allergic drugs have emerged, which has made all pharmaceutical companies instantly sensitive and immediately convened the company's expert team to conduct paper research.

The results of the study are very certain that if the drug is effective, then this is a pioneering and subversive drug in asthma and allergic diseases.

Asthma and allergic diseases are common diseases. Because it is common, more people take medication. There is no need to calculate the high sales and profits. Think about it and know how big the cake will be.

If nothing unexpected happens, the profit will even exceed that of omeprazole.

This is different from the use of drugs for rare diseases. Although rare diseases are expensive, tens of thousands or even millions of dollars, there are few people using them.

The reason is that there are few patients with rare diseases. The key is that the drug price is expensive and not everyone can afford it, so the profit is actually that way.

If many rare disease drugs were not subject to government subsidies, relevant scientific research and production would be difficult to sustain.

Just like the simplest, everyone has heard of snake venom, the only life-saving drug at critical moments.

However, there are few people using snake venom serum, the manufacturers are unwilling to produce, and the hospitals are unwilling to purchase goods. They are all the ones who lose money when they expire.

This also led to the fact that many patients were bitten by snakes and sent to several hospitals because most of the domestic hospitals do not have snake venom serum.

Other drugs such as amyotrophic lateral sclerosis (amyotrophic cervix), Crohn's disease, multiple sclerosis, pulmonary hypertension, hemophilia, and cancer are all expensive and rare.

Although these rare diseases are expensive, their profits are not high, and many of them may not even be able to make back their R&D expenses.

The senior executives of Lilai Pharmaceutical reached an agreement that, given that Xiangjiang Pumpkin Vine was previously reliable and the latest drugs developed were all popular, they also wanted to interfere.

The company's chairman is Paulke. This is an old man in his 70s. He can become a corporate giant in a bad country, and he is all a thousand-year-old fox.

As a capital society, it is completely useless to achieve its goals. No matter whether you cheat or steal, as long as you can get these drugs.

At the closed-door board meeting, Paulke knocked on the table and said in a deep voice:

"This time, our company must send people to the International Medical Forum held in China. It is best to get the patent authorization of Xiangjiang Pumpkin Vine. If you can't get it, find a way to get a few of their medicines back."

How many medicines are coming back? Why?

Everyone in the office knew it well that the world's medicine was copied, and it seemed that the old fox was not at ease.

President Svift had a headache: "Chairman, the question is that we didn't receive the invitation, what should we do?"

"I'll handle the invitation. This time the Mayo Clinic received an invitation. I will ask their vice chairman Child Steve to arrange for you to enter their delegation, Svift, this time you go to China in person."

"Okay, Chairman."

The same conference was held in different pharmaceutical companies. The difference is that some companies really want to cooperate, while some companies, such as Lilai Pharmaceuticals, have not been so simple.

Yes, some companies have a very simple idea. If you don’t cooperate with me, I will imitate your medicine this time. At worst, I can change it slightly.

What? Want to sue me? Then sue me.

The judicial procedures in European and American countries are not ordinary cumbersome. Courts alone are divided into many levels, such as state courts, federal courts, circuit courts, Supreme Courts, etc., and the lawsuits are fought at first level, but they will not be concluded in a few years.

It depends on who can consume whom. Can your small company in Xiangjiang compete with the pharmaceutical giants in financial resources? It will drag you to death.

This is something they have tried and tested before, and the facts have proved very effective and none of them failed.

The capital path has always been bloody.

Chen Xia didn't know the little thoughts of the pharmaceutical giants in various countries, and it didn't matter even if he knew it. Anyway, he didn't have the way to "harm others and not benefit himself".

Even if there is nothing in the end, this is not a big deal for Pumpkin Vine Pharmaceutical Company. There are so many medicines in the space hospital, so what if there are more one more one less one?

Now he is not worried about whether his own medicine can make money happily

What he had a headache was that he encountered a medical dispute in the hospital where he was, and he was a group of people with a deep background.
Chapter completed!